Evidence map›Paper›PMID 30060115›Full record

ArticleEuropean heart journal2018

Antithrombotic treatment is associated with intraplaque haemorrhage in the atherosclerotic carotid artery: a cross-sectional analysis of The Rotterdam Study.

Blerim Mujaj, Daniel Bos, Taulant Muka, Aad van der Lugt, M Arfan Ikram, Meike W Vernooij, Bruno H Stricker, Oscar H Franco

Abstract read
In one paragraph

Article in European heart journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Review
  7. Observational
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Sonodynamic therapy reduces iron retention of hemorrhagic plaque.Bioengineering & translational medicine · 2021
    Article
  20. Experimental and therapeutic medicine · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Blerim MujajDepartment of Epidemiology, Erasmus MC, Rm Na-2717, CA Rotterdam, the Netherlands.
Daniel BosDepartment of Epidemiology, Erasmus MC, Rm Na-2717, CA Rotterdam, the Netherlands.
Taulant MukaDepartment of Epidemiology, Erasmus MC, Rm Na-2717, CA Rotterdam, the Netherlands.
Aad van der LugtDepartment of Radiology and Nuclear Medicine, Erasmus MC, CA Rotterdam, the Netherlands.
M Arfan IkramDepartment of Epidemiology, Erasmus MC, Rm Na-2717, CA Rotterdam, the Netherlands.
Meike W VernooijDepartment of Epidemiology, Erasmus MC, Rm Na-2717, CA Rotterdam, the Netherlands.
Bruno H StrickerDepartment of Epidemiology, Erasmus MC, Rm Na-2717, CA Rotterdam, the Netherlands.
Oscar H FrancoDepartment of Epidemiology, Erasmus MC, Rm Na-2717, CA Rotterdam, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: Antithrombotic treatment plays a key role in stroke prevention, but their direct effects on the composition of carotid artery atherosclerotic plaques are unknown. To investigate the association of antithrombotic treatment with carotid artery plaque composition, with a specific focus on an intraplaque haemorrhage (IPH). Methods and results: From the population-based Rotterdam Study, 1740 participants with carotid atherosclerosis on ultrasound (mean age 72.9 years, 46.0 women) underwent magnetic resonance imaging of the carotid arteries to assess plaque composition. Information on the use of oral anticoagulants [vitamin K antagonists (VKA)] and antiplatelet agents (salicylates), including duration of use and dosage, was obtained from pharmacy records for all participants. We used logistic regression models to assess the association between the use of anticoagulants and antiplatelet agents, and the different plaque components adjusting for confounders. Current and past use of VKA [adjusted odds ratio (OR): 1.88, 95% confidence interval (CI): 0.74-4.75 and OR 1.89, 95% CI: 0.91-3.93] and antiplatelet agents (OR: 1.22, 95% CI: 0.91-1.62), and (OR: 1.23, 95% CI: 0.86-1.75) showed positive trend with a higher presence of IPH. Also, a longer duration of use was associated with a higher frequency of IPH (OR: 3.15, 95% CI: 1.23-8.05) for the use of VKA, and longer duration of the use for antiplatelet agents showed a positive trend (OR: 1.21, 95% CI: 0.88-1.67). We also found that higher levels of international normalized ratio above 2.97 for VKA (OR: 1.48, 95% CI: 1.03-2.15) and higher daily defined dosage than 1.0 for antiplatelet agents (OR: 1.50, 95% CI: 1.21-1.87) were related to a higher frequency of IPH. We found no association with lipid core or calcification. Conclusions: The use of antithrombotic treatment relates to a higher frequency of IPH in carotid atherosclerotic plaques.

Indexed as

AgedAnticoagulantsCarotid Artery DiseasesCross-Sectional StudiesDrug Administration ScheduleFemaleFibrinolytic AgentsHemorrhageHumansMagnetic Resonance ImagingMaleMiddle AgedPlaque, AtheroscleroticPlatelet Aggregation InhibitorsProspective StudiesRisk FactorsAnticoagulantsFibrinolytic AgentsPlatelet Aggregation InhibitorsVitamin K

Identifiers

PMID30060115
PMCPMC6148524

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.